tris(2,2,6,6-tetramethyl-3,5-heptanedionato)gallium(iii)

Modify Date: 2024-01-30 20:15:50

tris(2,2,6,6-tetramethyl-3,5-heptanedionato)gallium(iii) Structure
tris(2,2,6,6-tetramethyl-3,5-heptanedionato)gallium(iii) structure
Common Name tris(2,2,6,6-tetramethyl-3,5-heptanedionato)gallium(iii)
CAS Number 34228-15-4 Molecular Weight 619.52500
Density N/A Boiling Point 360ºC
Molecular Formula C33H57GaO6 Melting Point 219-220ºC
MSDS N/A Flash Point N/A

 Names

Name (Z)-5-bis[[(Z)-2,2,6,6-tetramethyl-5-oxohept-3-en-3-yl]oxy]gallanyloxy-2,2,6,6-tetramethylhept-4-en-3-one
Synonym More Synonyms

 Chemical & Physical Properties

Boiling Point 360ºC
Melting Point 219-220ºC
Molecular Formula C33H57GaO6
Molecular Weight 619.52500
Exact Mass 618.34100
PSA 78.90000
LogP 8.65670
Appearance of Characters crystal | white

 MSDS


Section 1: Product Identification
Chemical Name:Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)gallium (III), 99% (99.999%-Ga) [Ga(TMHD)3] PURATREM
CAS Registry Number:34228-15-4
Formula:Ga(C11H19O2)3
EINECS Number:none
Chemical Family:metal beta-diketonate complexes
Synonym:Dipivaloylmethane, gallium complex

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title Compound34228-15-4100%no datano data

Section 3: Hazards Identification
Emergency Overview:No particular hazard associated with this material. May be irritating to skin, eyes and respiratory tract.
Primary Routes of Exposure:Ingestion, inhalation
Eye Contact:May cause slight to mild irritation of the eyes.
Skin Contact:May cause slight to mild irritation of the skin.
Inhalation:May be irritating to the nose, mucous membranes and respiratory tract.
Ingestion:No specific information is available on the physiological effects of ingestion.
Acute Health Affects:May be irritating to skin, eyes and respiratory tract.
Chronic Health Affects:No information available on long-term chronic effects.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with soap and water. Remove contaminated clothes if necessary. Seek medical
Skin Exposure:
assistance if irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Ingestion:Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious).

SECTION 5: Fire Fighting Measures
Flash Point:not applicable
Autoignition Temperature:none
Explosion Limits:none
Extinguishing Medium:carbon dioxide, dry powder or foam
If involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained
Special Fire Fighting Procedures:
breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit toxic organic fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures:Small spills can be mixed with vermiculite or sodium carbonate and swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a sealed container. Keep away from heat and moisture.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear appropriate chemical resistant gloves and protective clothing.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
If in form of fine dust and ventilation is not available a respirator should be worn. The use of respirators
Respirator:
requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:white xtl.
Molecular Weight:619.54
Melting Point:219-220°
Boiling Point:dec.360°C subl.170°/.2mm
Vapor Pressure:subl. 170°/0.2mm
Specific Gravity:no data
Odor:none
Solubility in Water:Insoluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable solid
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:none
Incompatibility:Oxidizing agents
Decomposition Products:Carbon dioxide, carbon monoxide, organic vapors, and metal oxides and carbonates.

SECTION 11: Toxicological Information
RTECS Data:No information available in the RTECS files.
Carcinogenic Effects:No data available
Mutagenic Effects:No data available
Tetratogenic Effects:No data available

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Not listed in the TSCA inventory.
SARA (Title 313):Title compound not listed.
Second Ingredient:none


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Synonyms

gallium iii 2,2,6,6-tetramethylheptanedionate
MFCD00058705
Hot Compounds More...
Dichloromethane
CAS#:75-09-2
Polyacrylic acid
CAS#:9003-01-4
sodium carbonate
CAS#:497-19-8
Silicon dioxide
CAS#:7631-86-9
Triethanolamine
CAS#:102-71-6
Demeton
CAS#:126-75-0
Water
CAS#:7732-18-5
4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9
Diclofenac sodium
CAS#:15307-79-6
Budesonide
CAS#:51372-29-3